Skip to content
Home/Companies/Biotech/IAMA Therapeutics
IT

IAMA Therapeutics

Biotech·Italy·Active·1yr hold

IAMA Therapeutics is a biotech company, headquartered in Italy.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns IAMA Therapeutics?

IAMA Therapeutics is currently owned by Indaco Venture Partners SGR through Indaco BIO (2022 vintage), since 2025.

Hand-verified · updated 2026-07-23

Indaco Venture Partners SGR
Investor
Indaco Venture Partners SGR
Indaco BIO · 2022 · Life Sciences VC

Key facts

HQItaly
SectorBiotech
StatusActive

More from Indaco BIO

Other portfolio companies in the same fund.

Tes Pharma
Active
PharmaItaly· 2025
Valo Therapeutics
Active
BiotechFinland· 2025
Genespire
Active
BiotechItaly· 2024
Micthera
Active
BiotechItaly· 2024
Freya Biosciences
Active
BiotechDenmark· 2023
Hoba Therapeutics
Active
BiotechSwitzerland· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings